Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Latch, Azure, Abbott, and TuSimple and Encourages Investors to Contact the Firm
On this news, Latchs stock fell $0.13, or 12.2%, to close at $0.95 per share on August 26, 2022, on unusually heavy trading volume.
- On this news, Latchs stock fell $0.13, or 12.2%, to close at $0.95 per share on August 26, 2022, on unusually heavy trading volume.
- For more information on the Azure class action go to: https://bespc.com/cases/AZRE
Abbott manufactures various forms of infant formula including formula sold under the brand names Similac, Alimentum, and EleCare. - For more information on the TuSimple class action go to: https://bespc.com/cases/TSP
About Bragar Eagel & Squire, P.C. - The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.